• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 231/14

Total number of patents in this class: 1166

10-year publication summary

71
93
79
71
76
79
66
54
48
35
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bayer Cropscience AG
1846
58
Theravance Biopharma R&D IP, LLC
407
48
BASF SE
21303
35
Syngenta Participations AG
1527
34
Syngenta Crop Protection AG
6699
33
BioCryst Pharmaceuticals, Inc.
182
31
Orion Corporation
770
19
Takeda Pharmaceutical Company Limited
2715
18
Sumitomo Chemical Company, Limited
8996
15
Activesite Pharmaceuticals, Inc.
18
15
Loxo Oncology, Inc.
84
12
Solvay SA
945
12
Syngenta Limited
427
11
Dow AgroSciences LLC
1188
11
Research Triangle Institute
418
11
sanofi-aventis
302
11
Hoffmann-La Roche Inc.
3783
10
AstraZeneca AB
2818
10
Bayer Intellectual Property GmbH
2379
10
Rezolute, Inc.
33
10
Other owners 752